Christian Reicherts

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

Matthias Stelljes, Jan Moritz Middeke, Gesine Bug et al. · The Lancet Haematology · 2024 · 49 citations · Full text

Medicine, Hematology, Oncology +15

In Patients with Relapsed/Refractory AML Sequential Conditioning and Immediate Allogeneic Stem Cell Transplantation (allo-HCT) Results in Similar Overall and Leukemia-Free Survival Compared to Intensive Remission Induction Chemotherapy Followed By Allo-HCT: Results from the Randomized Phase III ASAP Trial

Matthias Stelljes, Jan Moritz Middeke, Gesine Bug et al. · Blood · 2022 · 42 citations

Medicine, Oncology, Chemotherapy +12

Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome

Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland et al. · Nature Cancer · 2024 · 38 citations

Life Sciences, Immunology, Neuroscience +12

Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease

Christoph Groth, Lenneke F. J. van Groningen, Tiago R. Matos et al. · Biology of Blood and Marrow Transplantation · 2018 · 34 citations · Full text

Life Sciences, Immunology, Pharmacology +17

High‐dose melphalan‐based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemia

Nina K. Steckel, Christoph Groth, Jan‐Henrik Mikesch et al. · British Journal of Haematology · 2018 · 33 citations

Medicine, Hematology, Oncology +15